OXYCURE
ActiveSummary
OXYCURE has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.42M and a net result of €18k. Equity is shrinking by ~9.3% per year across the filed fiscal years. Its solvency ranks better than 33% of 4157 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
68
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79▲+2
Solvency47▲+2
Growth32▼-1
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €160k at 30 days acceptable
Liquidity tight (current ratio 1.24 against 1.36 in 2024; short-term debt: 29.5% and cash: 9.3% of total assets), and 78.4% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
21.6%
Return on assets
0.2%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 d early
2024
24 d late
2023
8 d early
2022
on the day
2021
8 d late
2020
1 d late
2019
3 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€13.83M▼ 2.4%
2024 · €14.18M
2023: €14.15M
2024: €14.18M
2023 → 2025
EBIT margin
2.0%▲ 1.6pp
2024 · 0.4%
2023: -9.3%
2024: 0.4%
2023 → 2025
Net result
€18k
2024 · €-258k
2019: €205k
2020: €772k
2021: €478k
2022: €-467k
2023: €-1.31M
2024: €-258k
2019 → 2025
Working capital
€795k▼ 34.1%
2024 · €1.21M
2019: €-658k
2020: €-254k
2021: €-1.41M
2022: €-159k
2023: €-742k
2024: €1.21M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€14.15M€14.18M▲ 0.2%€13.83M▼ 2.4%
Equity€4.41M-€3.94M▼ 10.6%€2.67M▼ 32.3%€2.41M▼ 9.8%€2.42M▲ 0.5%
Operating result€738k-€-406k€-1.32M▼ 224%€57k€275k▲ 380%
Net result€478k-€-467k€-1.31M▼ 181%€-258k▲ 80.3%€18k
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 380% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €11.22M
Fixed assets
€7.11M ▼ 8.6%
Current assets
€4.10M ▼ 9.9%
Equity and liabilities €11.22M
Equity
€2.42M ▲ 0.5%
Provisions
€206k ▼ 2.1%
Debt
€8.59M ▼ 11.6%
Debt's share of the balance-sheet total falls from 78.8% to 76.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€2.91M▼
2024 · €3.16M
Cash flow
€2.65M▼
2024 · €2.85M
Current ratio
1.24▼
2024 · 1.36
Quick ratio
1.13▼
2024 · 1.25
Debt to equity
3.55▼
2024 · 4.04
ROE
0.7%▲
2024 · -10.7%
ROA
0.2%▲
2024 · -2.1%
Interest coverage
11.13▼
2024 · 12.77
Debt ≤ 1 year
€3.31M▼
2024 · €3.35M
Debt > 1 year
€5.28M▼
2024 · €6.32M
Income taxes
€1▼
2024 · €71k
Staff costs
€4.37M▲
2024 · €4.34M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 83 lines
Balance sheet
Code20242025
Assets
Total assets20/58€12.33M€11.22M▼
Fixed assets21/28€7.78M€7.11M▼
Intangible fixed assets21€770k€647k▼
Tangible fixed assets22/27€7.00M€6.46M▼
Land and buildings22€2.82M€2.52M▼
Plant, machinery and equipment23€457k€399k▼
Furniture and vehicles24€194k€129k▼
Leasing and similar rights25€631k€686k▲
Other tangible fixed assets26€2.90M€2.73M▼
Financial fixed assets28€3k€3k=
Other financial fixed assets284/8€3k€3k=
Amounts receivable and cash guarantees285/8€3k€3k=
Current assets29/58€4.56M€4.10M▼
Amounts receivable after more than one year29€10k€14k▲
Other amounts receivable291€10k€14k▲
Stocks and contracts in progress3€380k€373k▼
Stocks30/36€380k€373k▼
Goods purchased for resale34€380k€373k▼
Amounts receivable within one year40/41€2.93M€2.45M▼
Trade receivables40€2.93M€2.45M▼
Other amounts receivable41€1k€1k▲
Cash at bank and in hand54/58€1.06M€1.04M▼
Deferred charges and accrued income490/1€174k€223k▲
Equity and liabilities
Total equity and liabilities10/49€12.33M€11.22M▼
Equity10/15€2.41M€2.42M▲
Contributions10/11€998k€998k=
Capital10€998k€998k=
Issued capital100€998k€998k=
Reserves13€100k€100k=
Non-distributable reserves130/1€100k€100k=
Legal reserve130€100k€100k=
Profit (loss) carried forward14€1.28M€1.29M▲
Investment grants15€33k€28k▼
Provisions and deferred taxes16€211k€206k▼
Provisions for liabilities and charges160/5€211k€206k▼
Other liabilities and charges164/5€211k€206k▼
Amounts payable17/49€9.72M€8.59M▼
Amounts payable after more than one year17€6.32M€5.28M▼
Financial debts170/4€6.32M€5.28M▼
Subordinated loans170€2.67M€2.56M▼
Leasing and similar obligations172€297k€369k▲
Credit institutions173€3.36M€2.35M▼
Amounts payable within one year42/48€3.35M€3.31M▼
Current portion of amounts payable after more than one year42€1.68M€1.43M▼
Trade debts44€750k€955k▲
Suppliers440/4€750k€955k▲
Taxes, remuneration and social security45€880k€872k▼
Taxes450/3€247k€211k▼
Remuneration and social security454/9€633k€661k▲
Other amounts payable47/48€40k€47k▲
Accrued charges and deferred income492/3€48k€650▼
Income statement
Code20242025
Operating income70/76A€14.65M€14.18M▼
Turnover70€14.18M€13.83M▼
Other operating income74€313k€348k▲
Non-recurring operating income76A€163k-
Operating charges60/66A€14.59M€13.91M▼
Goods for resale, raw materials and consumables60€802k€575k▼
Purchases600/8€704k€568k▼
Change in stocks: decrease (increase)609€99k€7k▼
Services and other goods61€6.25M€6.23M▼
Remuneration, social security and pensions62€4.34M€4.37M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.11M€2.63M▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€8k€-12k▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€12k€-4k▼
Other operating charges640/8€72k€74k▲
Non-recurring operating charges66A€5k€50k▲
Operating profit (loss)9901€57k€275k▲
Financial income75/76B€3k€5k▲
Recurring financial income75€3k€5k▲
Income from current assets751-€2
Other financial income752/9€3k€5k▲
Financial charges65/66B€248k€263k▲
Recurring financial charges65€248k€263k▲
Debt charges650-€261k
Other financial charges652/9€248k€1k▼
Profit (loss) for the period before taxes9903€-188k€18k▲
Income taxes67/77€71k€1▼
Taxes670/3€71k€1▼
Profit (loss) for the period9904€-258k€18k▲
Profit (loss) for the period to be appropriated9905€-258k€18k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.28M€1.29M▲
Profit (loss) brought forward from the previous period14P€1.53M€1.28M▼
Social balance
Average headcount (FTE)908761.960.1▼
The notes to these accounts (84 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-01
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
30-06
Financial
Back to profitnet €18k
Net result €18k after 3 loss-making years.
24-02
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 24 days late
2024
23-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-06
Financial
Weakest financial yearnet €-1.31M
Net result drops to €-1.31M, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
08-02
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 8 days late
2021
01-02
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 1 day late
2020
30-06
Financial
Highest result since 2019net €772k ▲277%
Operating result €1.08M, net result €772k, both a record.
03-02
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 3 days late
2019
05-02
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 5 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
10-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Fernelmont · 1 establishment unit since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Léopold Genicot, ZI, Nov. 95380 Fernelmont1 establishment unit
Rue Léopold Genicot, ZI, Nov. 9, 5380 Fernelmont
since 20022.087.894.514
Recognitions · licences · registrations
Legal Entity Identifier
549300PIR0MJYC0ADB31
Similar companies · same sector, comparable size
ABFAB
BE 0459.847.603
Anderlecht · Eq €2.44M
PROSANA
BE 0734.442.824
Oud-Turnhout · Eq €2.39M
Centre pharmaceutique de Louvain-la-Neuve
BE 0412.749.054
Ottignies-Louvain-la-Neuve · Eq €2.45M
TERVEST
BE 0500.522.275
Tervuren · Eq €2.50M
FARMAZORG
BE 0828.830.158
Oudenburg · Eq €2.33M
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,099 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded28-05-1998
Fiscal year end30-06
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
86995Nutrition and dietetics services
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
70200Business and other management consultancy
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 27 filings
Scores and ratios are computed by Checked and are not a credit decision.